Raymond James Financial Services Advisors, Inc. Ptc Therapeutics, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2018 Jul 30, 2018	SELL	$25.7 - $47.88 $259,133 - $482,774	-10,083 Closed	0 $0
Q1 2018 Apr 16, 2018	BUY	$17.46 - $32.59 $176,049 - $328,604	10,083 New	10,083 $273,000

Others Institutions Holding PTCT

# of Institutions

222

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

Vanguard Group Inc Valley Forge, PA

9.13M
Shares

$456 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

7.89M
Shares

$395 Million
0.05% of portfolio
Black Rock Inc. New York, NY

7.77M
Shares

$389 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

7.39M
Shares

$370 Million
4.37% of portfolio
Armistice Capital, LLC New York, NY

7.23M
Shares

$362 Million
4.46% of portfolio

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.58B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account